Quick Answer
Twist Bioscience Corp reported Total Assets of $641.86 million for the year ending 2025.
- Twist Bioscience Corp showed an increase of +4.5% in Total Assets from 2024 to 2025.
- This data is from Twist Bioscience Corp's annual report (Form 10-K), filed with the SEC on November 17, 2025.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2018: $164.45 million | Q1 2019: $140.17 million | Q2 2019: $206.81 million | Q4 2019: $192.28 million | Q1 2020: $323.87 million | Q2 2020: $408.24 million | Q4 2020: $699.57 million | Q1 2021: $677.29 million | Q2 2021: $725.30 million | Q4 2021: $786.17 million | Q1 2022: $1.02 billion | Q2 2022: $979.66 million | Q4 2022: $909.97 million | Q1 2023: $853.92 million | Q2 2023: $810.33 million | Q4 2023: $732.82 million | Q1 2024: $702.85 million | Q2 2024: $638.12 million | Q4 2024: $608.58 million | Q1 2025: $595.62 million | Q2 2025: $643.61 million | Q3 2025: $641.86 million | Q4 2025: $638.09 million.
- Over the full 8 years of available data (2018 to 2025), Twist Bioscience Corp's Total Assets has grown by 454.3%.
- Historical annual values: Fiscal year 2025: $641.86 million | Fiscal year 2024: $614.32 million | Fiscal year 2023: $776.40 million | Fiscal year 2022: $961.38 million | Fiscal year 2021: $702.10 million | Fiscal year 2020: $398.88 million | Fiscal year 2019: $186.99 million | Fiscal year 2018: $115.79 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: